📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A panel of urinary proteins predicts active lupus nephritis and response to rituximab treatment. (2021)

First Author: Davies JC

Attributed to: MAximizing Sle ThERapeutic PotentiaL by Application of Novel and Stratified approaches (MASTERPLANS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/rheumatology/keaa851

PubMed Identifier: 33313921

Publication URI: http://europepmc.org/abstract/MED/33313921

Type: Journal Article/Review

Volume: 60

Parent Publication: Rheumatology (Oxford, England)

Issue: 8

ISSN: 1462-0324